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1. Introduction 
There has been a resurgence of interest in recent years in the systemic effects of oral 
infections such as periodontal diseases. The study of the various means by which 
periodontal infections and inflammation may influence a variety of systemic conditions is 
collectively referred to as periodontal medicine. The periodontium responds to tooth-borne 
biofilm (dental plaque) by the process of inflammation. Dental biofilms release a variety of 
biologically active products, such as bacterial lipopolysaccharides (endotoxins), chemotactic 
peptides, protein toxins, and organic acids. These molecules stimulate the host to produce a 
variety of responses, among them the production and release of potent agents known as 
cytokines. These include interleukin-1 beta, interleukin-8, prostaglandins, and tumor 
necrosis factor-alpha. There is a spectrum of periodontal response to these molecules, from 
mild gingivitis to severe destructive periodontitis. These and other host products and 
responses may influence a variety of important disease pathways, including atherosclerosis, 
mucosal inflammation, and premature parturition. The purpose of this chapter is to review 
the possible biological pathways by which periodontal diseases may influence these disease 
processes. 
There has been increasing attention paid in recent years to the possibility that oral bacteria 
and oral inflammation, particularly periodontal diseases, may influence the initiation 
and/or progression of several systemic disease processes. This, of course, is not a novel 
concept. Indeed, the focal-infection hypothesis, which grew from the principles of infectious 
disease first established by Koch and Pasteur in the mid-19th century, put forth the notion 
that the invasion of the bloodstream by bacteria from a localized infection (such as 
periodontal diseases) could spread to distant organs and tissues to cause disease.1-3 In fact, 
this hypothesis was so convincing to practitioners of the time that tonsillectomy and full-
mouth extraction enjoyed widespread implementation to treat many diseases, regardless of 
whether or not infection could be proven to be the cause. However, because it became clear 
that it was impossible to correlate with confidence a particular systemic disease with a 
preceding oral infection or dental procedure, the focal-infection hypothesis fell from favor 
by the middle of the 20th century. Yet, interest in the systemic effects of periodontal 
infection was reignited in the early 1990s by a series of case-control and other epidemiologic 
studies that demonstrated statistical associations between poor oral health and several 
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systemic diseases. The goal of this chapter is to describe the biologically plausible 
circumstances that underlie these potential associations. The reader is further referred to 
recent definitive reviews on the pathogenesis of periodontal disease for specific details that 
are beyond the scope of this chapter.4,5  
The periodontium responds to the tooth-borne biofilm, long known as dental plaque, by the 
process of inflammation. Plaque is composed of numerous bacteria, comprising over 700 
species, which tenaciously adhere to the tooth surface.6 Scientists are now beginning to 
understand the complex molecular interactions that occur, for example, between the bacteria 
and salivary pellicle that coats the tooth, and between gram-positive cocci of early plaque 
and gram-negative filamentous bacteria that populate the tooth as plaque matures.7 Recent 
work has elucidated complex signaling pathways (referred to as quorum sensing) between 
bacteria, mediated by soluble chemicals produced by the bacteria that control biofilm 
development.8 It is anticipated that this knowledge will eventually yield sophisticated strate-
gies to limit the pathogenic potential of dental plaque.  
Within a few hours of meticulous tooth cleaning, bacteria colonize the tooth surface 
primarily around the gingival margin and interdental spaces (Figure 1).9 The developing 
biofilm releases a variety of biologically active products, including lipopolysaccharides 
(endotoxins), chemotactic peptides, protein toxins, and organic acids.4 These molecules 
diffuse into the gingival epithelium to initiate the host response that eventually results in 
gingivitis and, in some circumstances, inflammatory periodontal diseases.4 Clinically, 
gingivitis is characterized by a change in color—from normal pink to red—with swelling 
and, often, sensitivity and tenderness.10 Gentle probing of the gingival margin typically 
elicits bleeding.10 Because gingivitis is often not painful, it may remain untreated for many 
years.  
Epidemiologically, the prevalence of gingivitis in non-Hispanic whites is approximately 50% 
of the population, with up to 63% in Mexican Americans showing clinical signs of the 
disease.11 It is quite possible that this rate is somewhat understated because it is possible that 
gingivitis, in its most nascent form, is clinically undetectable. Periodontitis affects 
approximately 35% of dentate US adults 30 to 90 years of age, with 21% having a mild form 
and 12% having a moderate or severe form of the disease.12 Thus, gingivitis is much more 
widespread than periodontitis in the US population.  
Histopathologically, gingival inflammation presents as a spectrum of severity in humans.7 In 
a relatively small subset of the population, the gingiva are virtually devoid of inflammatory 
infiltrate, the so-called “pristine gingiva” (Figure 2).7 These subjects practice impeccable oral 
hygiene and demonstrate no clinical signs of inflammation. More widespread would be the 
“normal healthy gingiva,” which demonstrates a mild-to-moderate inflammatory infiltrate. 
Clinically, these two conditions would appear indistinguishable in that the tissues would 
appear quite healthy.  
Probably most prevalent in the population is established gingivitis that is associated with a 
more widespread biofilm and clear clinical symptomology (redness, swelling, and bleed-
ing), and histopathologically showing significant inflammatory infiltration (Figure 3).7  The 
most severe form of periodontal diseases results in the destruction of the periodontal 
ligament and supporting osseous tissue and, ultimately, exfoliation of the teeth. Perio-
dontitis is associated with extensive formation of biofilm dominated by anaerobic, gram-
negative bacteria and spirochetes.13  
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Fig. 1. Biochemical events in periodontal disease. Pristine gingiva are not exposed to 
significant numbers of plaque microorganisms to yield a host response. Few signs of acute 
inflammation or cellular infiltrate are noted. 
 
 
Fig. 2. Left panel: Pristine gingiva is found in subjects with impeccable oral hygiene and 
minimal plaque. Gingival tissues are free of clinical signs of inflammation, and tissues are 
essentially free of inflammatory infiltrate. Right panel: Early gingivitis is found in subjects 
with some plaque formation. While the gingival tissues are free of clinical signs of 
inflammation, a mild inflammatory infiltrate is evident, consisting of vasculitis and the pres-
ence of neutrophils. 
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Fig. 3. Left panel: In the absence of effective plaque control, a robust inflammatory response 
results in clinical signs of inflammation (redness, edema, bleeding) and a significant 
inflammatory infiltrate, including neutrophils, lymphocytes, and evidence of collagen 
breakdown. Signs of periodontal attachment loss or alveolar bone loss are not evident. Right 
panel: The inflammatory response results in marked collagen breakdown, periodontal 
attachment and alveolar bone loss, and clinical signs of inflammation.  
As mentioned previously, initial dental plaque bacteria (typically gram-positive cocci and 
filaments) release a variety of chemical compounds during their normal metabolism 
(organic acids, chemotactic peptides, etc). These products are soluble and penetrate the 
superficial layers of the sulcular epithelium. These substances signal the epithelium of the 
gingiva to produce a variety of biologically active mediators, most prominently cytokines 
such as interleukin-1 beta (IL-1┚), interleukin8 (IL-8), prostaglandins, tumor necrosis factor-
alpha (TNF-┙), and matrix metalloproteinases (Figure 4). These products influence a 
number of cellular processes, including the recruitment and chemotaxis of neutrophils to the 
site, with increased permeability of the gingival vessels that results in extravasation of 
plasma proteins from the blood vessels into the tissue. The epithelium also responds by 
induction of innate defense systems, which include the production of antimicrobial 
peptides, such as defensins, calprotectin, etc.14 In addition, the salivary defense system 
works to limit bacterial growth through the flushing action of simple fluid flow that clears 
bacteria from the oral surfaces, bacterial-aggregation factors, antimicrobial proteins, etc.15  
Should the dental plaque biofilm continue to grow and expand to populate the subgingival 
space, these noxious compounds will stimulate the epithelium to produce bioactive 
mediators, resulting in further recruitment of a variety of cell types, including neutrophils, 
T-cells, monocytes, etc (Figure 5). The resulting established or chronic gingivitis is the most 
prevalent type of gingival inflammatory lesion in the population as a whole. Thus, 
continued exacerbation of the process results in signaling of underlying cell types, including 
fibroblasts, to increase production of proinflammatory cytokines in the tissues. Host 
systemic responses to this insult also can be documented. For example, evidence of specific 
antibodies to oral organisms can be demonstrated in peripheral blood. Also, the acute-phase 
response is associated with gingival inflammation, including the production of C-reactive 
protein (CRP), fibrinogen, complement, etc, by both local cells and the liver.16,17 These 
proteins not only possess biological activities that may further exacerbate the inflammatory 
response, they may also impact the initiation or progression of systemic disease processes, 
such as atherosclerosis.18,19  
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Fig. 4. Bacteria in dental plaque release biologically active components, including 
lipopolysaccharides, chemotactic peptides, and fatty acids. These components signal 
gingival epithelial cells to release proinflammatory cytokines that diffuse into the 
underlying connective tissues to stimulate acute vasculitis, which leads to dilation of blood 
vessels and extravasation of plasma components into the connective tissue compartment. 
Chemotactic peptides signal white cells to interact with and stick to vascular endothelium, 
after which the neutrophils enter the connective tissues. In addition to the inflammatory 
response, the host attempts to clear itself of microorganisms by responding to these signals 
with epithelial production of antimicrobial peptides. Saliva also affords numerous 
antimicrobial mechanisms to protect the host 
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Fig. 5. Increased numbers and increasing diversity of bacteria in dental plaque continue to 
release biologically active components that increase the intensity and spread of the 
inflammatory response. Increased numbers of neutrophils, monocytes, and macrophages 
infiltrate the tissues to release more diverse cytokines and prostaglandins that exacerbate 
the inflammatory response. Lymphocytes (T-and B-cells) and plasma cells also infiltrate, the 
latter releasing antibodies against the microorganisms that may also cross-react with the 
host tissues. The acute-phase response (including production of acute-phase proteins such 
as CRP, serum alpha amyloid A, and fibrinogen) also is evident. 
To this point, rigorous tooth cleaning and oral hygiene procedures would reverse the course 
of gingivitis and return the periodontium to a healthy state.20 Unfortunately, however, many 
people fail to maintain adequate hygiene and so the process of inflammation often continues 
unchecked for years.  In some individuals, for reasons that are not entirely clear, the 
inflammatory process expands to involve the breakdown of collagen in periodontal 
ligament and bone resorption, resulting in periodontitis (Figure 6). The rate of breakdown 
varies between individuals. It has been suggested that there are underlying genetic 
mechanisms or other risk factors (e.g., smoking, diabetes, stress, etc) that provoke these 
processes in certain people and not in others. We’ve heard lately of polymorphisms and 
various genes that control, for example, interleukin or fibrinogen synthesis. There is an 
ongoing scientific effort to determine the role of host genetics in the susceptibility to 
periodontal infection.21  
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Fig. 6. In some subjects, for reasons that remain unknown, the chronic inflammation of 
established gingivitis spreads to provoke periodontal ligament and alveolar bone 
destruction.  
2. Gingival health and bacteremia 
A consequence of this inflammatory process is ulceration of the gingival sulcular epitheli-
um, which allows bacterial translocation from the sulcus into the bloodstream. The surface 
area of the periodontal ligament has been calculated to cover about 75 square centimeters. 
Thus, a person having 50% horizontal bone loss and inflamed pocket epithelium would 
have a wound surface of approximately 30 to 40 square centimeters. Such a wound surface 
would likely increase the risk for bacterial translocation when compared to a healthy peri-
odontium. In the most prevalent periodontal disease, established gingivitis, pockets of 4 to 5 
millimeters may translate into a gingival wound surface area of 10 to 20 square centimeters. 
Considering that many people go a long time without having gingivitis treated, this chronic 
inflammatory condition may promote continuous, low-grade chronic bacteremia. Several 
studies have indeed shown that the incidence of bacteremia is elevated in subjects with 
increasing severity of gingival inflammation.22,23   When using rather insensitive bacterial 
culture techniques, bacteremia could be detected even in subjects with clinically healthy 
gingiva. The use of more sensitive molecular techniques, such as the polymerase chain 
reaction,24,25 would likely prove bacterial translocation from the periodontium to be even 
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more common than presently appreciated. While most studies of dentally related 
bacteremia have centered around purposeful activities such as tooth brushing, periodontal 
probing, and tooth extraction, it is possible that while participating in daily activities 
(chewing, speaking, habits, etc), minor disruptions to gingival integrity occur in a significant 
number of individuals with gingival inflammation. 
3. Gingival inflammation: Pathways of systemic effects  
Oral bacteria and gingival inflammation may theoretically influence systemic health 
through four potential pathways: bacteremia, systemic dissemination of locally produced 
inflammatory mediators, provocation of an autoimmune response, and aspiration or inges-
tion of oral contents into the gut or airway (Figure 7). Low-grade but persistent bacteremia 
may allow oral bacteria to aggregate platelets through receptor-ligand interactions. Studies 
have shown that infusing rabbits with aggregating bacteria caused significant hemodynamic 
changes, acute pulmonary hypertension, and cardiac abnormalities, including ischemia.26   
This very provocative work suggests that bacteremia of oral origin may have serious 
implications for systemic health.  
 
 
Fig. 7. Theoretical pathways by which the gingival inflammatory response may impact 
systemic inflammation and systemic processes such as atherosclerosis.  
www.intechopen.com
 Periodontal Inflammation: From Gingivitis to Systemic Disease? 163 
Several inflammatory mediators can be measured as being elevated in peripheral blood in 
subjects with periodontal disease,17 suggesting that periodontal inflammation either con-
tributes directly to the elevation of the concentration of these substances in peripheral blood 
or signals distant organs (e.g., the liver) to produce them. The liver could respond, for exam-
ple, through the acute-phase response by producing CRP, fibrinogen, etc. These proteins 
may have deleterious effects on other target organs (e.g., heart, brain) by modulating disease 
processes such as atherosclerosis.  Recent studies have suggested a connection between 
chronic infections, such as Chlamydia pneumoniae infection or periodontal diseases, and 
atherosclerosis.27 It has been suggested that immunity to bacterial pathogens plays a role in 
the atherosclerotic process and that this response may involve autoimmunity.28 It has been 
observed that almost all humans have immune reactions against microbial heat-shock 
protein 60 (HSP60). The human version of this protein is highly homologous with bacterial 
HSP60. It is possible that the immune response generated against the microbial version of 
this protein could cross-react with human HSP60 on arterial endothelial cells to influence 
the course of atherosclerosis.28 Bacteria thought to induce gingival inflammation may also 
stimulate an autoimmune response by presentation of cross-reactive epitopes that stimulate 
autoantibody or T-cell response reactive with host antigens, such as HSP60, to drive a 
proinflammatory response with cardiovascular effects.29,30  
Dental plaque and/or periodontal inflammation may influence pathogenic processes occur-
ring in distally contiguous mucosal surfaces, for example, in the respiratory or digestive 
tracts.31,32 Salivary hydrolytic enzymes, observed to be elevated in patients with 
periodontitis, can promote the adhesion of pathogenic bacteria to the oral surfaces, thereby 
altering oropharyngeal colonization patterns. It is also possible that periodontopathic 
bacteria stimulate the periodontium to release proinflammatory cytokines that, when 
aspirated or swallowed, alter mucosal surfaces to promote adhesion of pathogenic bacteria 
that cause diseases such as pneumonia or gastric ulcers.31,32 Finally, cytokines released from 
inflamed periodontal tissues may enter the respiratory tract in aspirated saliva, triggering 
the sequence of neutrophil recruitment, epithelial damage, and infection.31  
4. Gingival inflammation and systemic disease  
Several case-control studies33 published in the early 1990s found that patients with a history 
of myocardial infarction had worse oral health than control subjects (studies are 
summarized in the reference). This has led to a flurry of studies to verify these observations. 
While most of these studies support a modest association between periodontal diseases and 
the outcomes of atherosclerosis (of myocardial infarction, angina, or stroke), several studies 
have not supported this association. This is complicated by the absence of a standard 
definition or measures for periodontal diseases and that underlying mechanisms common to 
both periodontal diseases and atherosclerosis share common risk factors, such as lifestyle 
habits like cigarette smoking. It is possible that dental plaque stimulation of cytokine 
production in the periodontium may elevate levels of cytokines in the peripheral blood. This 
may in turn stimulate hepatic production of acute-phase proteins, such as CRP. These 
proteins could then induce vascular injury, atherogenesis , cardiovascular disease, and 
stroke. Several studies have shown that patients with periodontal diseases demonstrate 
elevated levels of CRP and fibrinogen, as well as peripheral white blood cells.17,34 Elevated 
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levels of these proteins have been suggested to be risk factors for cardiovascular disease.35-37 
Additional evidence has been reported for the possible direct role of bacteria in 
atherosclerosis. It has been reported that chronic disease agents, such as C pneumoniae, play 
a role in atherosclerotic plaque development. Recently it has been reported that the DNA of 
oral bacteria could be amplified directly from atherosclerotic plaques. It is, therefore, 
possible that these pathogens may play a role in the development and progression of 
atherosclerosis leading to coronary vascular disease  
Lung diseases such as hospital-acquired pneumonia and chronic obstructive pulmonary dis-
ease (COPD) also have been associated with poor oral health.31,38 It is possible that oral 
biofilms on the teeth may serve as a reservoir of infection for respiratory pathogenic 
bacteria. In subjects admitted to hospital intensive care units or nursing homes, bacteria 
such as Pseudomonas aeruginosa, Staphylococcus aureus, and enteric bacteria have been shown 
to colonize the teeth. These bacteria may then be released into the oral secretions to be 
aspirated into the lower airway to cause infection. It is also possible that inflammatory 
mediators, such as cytokines produced by the periodontium, released into the secretions 
also can be aspirated to have pro-inflammatory effects in the lower airway.  
Several epidemiologic studies have reported associations between poor oral health and 
COPD.39,40 One interesting observation found that lung function measured through  
spirometry is associated with measures of periodontal disease.40 In subjects stratified by 
periodontal attachment loss, those with more severe attachment loss tended to demonstrate 
less lung function than those with less attachment loss. Further research is necessary to 
dissect the contribution of periodontal inflammation from those of established etiologies, 
such as smoking on lung function.  
There also has been interest in the association between periodontal inflammation and 
adverse pregnancy outcomes.41,42 Unfortunately, adverse pregnancy outcomes, such as 
premature birth and low birth weight, are quite common events. This is a very significant 
public health problem in the United States, and has been associated with subclinical 
genitourinary or other infections. During parturition, the uterus is influenced by the 
hypothalamus through the production of oxytocin, which stimulates uterine contraction. 
Prostaglandins that are produced by the placenta also stimulate uterine contraction, which 
normally leads to birth in the third trimester (37 weeks). It is thought that chronic infections 
drive the inflammatory process, which leads to the release of inappropriate levels of 
prostaglandins and TNF-┙, which prematurely stimulates uterine contraction to promote 
preterm birth.  
It has been suggested that periodontal infection and the release of lipopolysaccharides and 
other biologically active molecules drive the process of inflammation, as described above. 
This results in the elevation of prostaglandins and TNF-┙ in the crevicular fluid. 
Lipopolysaccharides released from the oral cavity into the bloodstream may stimulate 
prostaglandins in the placenta, causing preterm birth. It is also possible, such as in ath-
erosclerosis, that cytokines in the periodontium may lead to elevated peripheral blood 
cytokine levels and stimulate hepatic production of acute-phase proteins that may influence 
the birth process. Very recent work has also found that periodontal pathogens, such as 
Fusobacterium nucleatum, may travel from the gingival sulcus to the placenta to cause 
preterm birth.43 Thus, it is possible that these bacteria may enter the bloodstream from the 
oral cavity to directly affect the birth process.  
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5. Summary  
Dental plaque drives periodontal inflammation, with gingivitis being the initial mani-
festation of this process. With appropriate intervention, this process can be reversed and the 
periodontium returned to a state of health (Figure 8). However, an exuberant local host 
response, including the synthesis of cytokines and antibodies, in some cases results in the 
destruction of periodontal ligament and supporting bone (periodontitis). Periodontitis is 
typically treated by removing the etiology (dental plaque) and returning the gingival tissues 
to health. Unfortunately, in many cases, periodontal disease goes untreated for many years. 
It is possible, then, for the systemic host response to this insult to contribute to disease 
processes that result in cardiovascular disease and stroke, respiratory disease, and adverse 
pregnancy outcomes.  
 
 
Fig. 8. Suspected interrelationships between gingival inflammation, systemic disease, and 
response to periodontal therapy. 
What is the status of periodontal medicine today? While there are a number of preliminary 
studies that point to an association between periodontal inflammation and several systemic 
conditions, as mentioned above, the data are equivocal. In many cases, there has been an 
emphasis on linking periodontal attachment loss with systemic disease. It is possible that the 
use of this outcome measure, which represents “historical” evidence for the disease without 
indicating the temporal sequence or duration of disease activity, may cloud the role of 
periodontal inflammation in this process. Future investigations are needed that use better 
definitions for periodontal disease and measures of how gingival inflammation and tooth 
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loss may best determine the role this localized, chronic disease process plays in the 
progression and severity of important systemic diseases.  
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